Epilepsy associated with cerebral cavernous malformations managed with stereotactic radiosurgery: an international, multicenter study
Language English Country Germany Media print-electronic
Document type Multicenter Study, Journal Article
PubMed
37405688
DOI
10.1007/s00415-023-11836-6
PII: 10.1007/s00415-023-11836-6
Knihovny.cz E-resources
- Keywords
- Cerebral cavernous malformation, Drug-resistant epilepsy, Epilepsy, Stereotactic radiosurgery,
- MeSH
- Epilepsy * complications MeSH
- Intracranial Arteriovenous Malformations * complications MeSH
- Hemangioma, Cavernous, Central Nervous System * complications surgery MeSH
- Humans MeSH
- Adolescent MeSH
- Follow-Up Studies MeSH
- Radiosurgery * MeSH
- Retrospective Studies MeSH
- Treatment Outcome MeSH
- Seizures drug therapy MeSH
- Check Tag
- Humans MeSH
- Adolescent MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
OBJECTIVE: Stereotactic radiosurgery (SRS) has been proposed as an alternative to resection for epilepsy control in patients with cerebral cavernous malformations (CCM) located in critical areas. METHODS: This multicentric, retrospective study evaluated seizure control in patients with a solitary CCM and a history of at least one seizure prior to SRS. RESULTS: 109 patients (median age at diagnosis 28.9 years, interquartile range (IQR) 16.4 years] were included. Prior to SRS, 2 (1.8%) were seizure-free without medication, 35 (32.1%) were seizure-free with antiseizure medications (ASM), 17 (15.6%) experienced an improvement of at least 50% in seizure frequency/intensity with ASM, and 55 (50.5%) experienced an improvement of less than 50% in seizure frequency/intensity with ASM. At a median follow-up of 3.5 years post-SRS (IQR: 4.9), 52 (47.7%) patients were Engel class I, 13 (11.9%) class II, 17 (15.6%) class III, 22 (20.2%) class IVA or IVB and 5 (4.6%) class IVC. For the 72 patients who had seizures despite medication prior to SRS, a delay > 1.5 years between epilepsy presentation and SRS decreased the probability to become seizure-free, HR 0.25 (95% CI 0.09-0.66), p = 0.006. The probability of achieving Engel I at the last follow-up was 23.6 (95% CI 12.7-33.1) and 31.3% (95% CI 19.3-50.8) at 2 and 5 years respectively. 27 patients were considered as having drug-resistant epilepsy. At a median follow-up of 3.1 years (IQR: 4.7), 6 (22.2%) of them were Engel I, 3 (11.1%) Engel II, 7 (25.9%) Engel III, 8 (29.6%) Engel IVA or IVB and 3 (11.1%) Engel IVC. INTERPRETATION: 47.7% of patients managed with SRS for solitary CCM presenting with seizures achieved Engel class I at the last follow-up.
Department of Neurological Surgery Hospices Civils de Lyon Lyon France
Department of Neurological Surgery University of Virginia 1215 Lee St Charlottesville VA 22908 USA
Department of Neurosurgery Koc University School of Medicine Istanbul Turkey
Department of Neurosurgery NYU Langone New York City NY USA
Department of Neurosurgery University of Alberta Edmonton Alberta Canada
Department of Radiation Oncology National Cancer Institute Cairo University Cairo Egypt
Department of Radiosurgery Rúber Internacional Hospital Madrid Spain
Department of Stereotactic and Radiation Neurosurgery Na Homolce Hospital Prague Czech Republic
Departments of Clinical Oncology Ain Shams University Cairo Egypt
Departments of Neurosurgery Ain Shams University Cairo Egypt
Division of Neurosurgery Université de Sherbrooke Centre de Recherche du CHUS Sherbrooke QC Canada
Division of RadiationOncology Department of Oncology University of Alberta Edmonton Alberta Canada
Dominican Gamma Knife Center and Radiology Department CEDIMAT Santo Domingo Dominican Republic
Extended Modular Program Faculty of Medecine Ain Shams University Cairo Egypt
Gamma Knife Center Cairo Nasser Institute Hospital Cairo Egypt
Gamma Knife Center Jewish Hospital Mayfield Clinic Cincinnati OH USA
Mediterraneo Hospital Neurosurgery Athens Greece
Neurosurgery Department Faculty of Medecine Benha University Qalubiya Egypt
See more in PubMed
Horne MA, Flemming KD, Su I-C et al (2016) Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data. Lancet Neurol 15:166–173. https://doi.org/10.1016/S1474-4422(15)00303-8 PubMed DOI PMC
Rosenow F, Alonso-Vanegas MA, Baumgartner C et al (2013) Cavernoma-related epilepsy: review and recommendations for management–report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 54:2025–2035. https://doi.org/10.1111/epi.12402 PubMed DOI
Josephson CB, Bhattacharya JJ, Counsell CE et al (2012) Seizure risk with AVM treatment or conservative management: prospective, population-based study. Neurology 79:500–507. https://doi.org/10.1212/WNL.0b013e3182635696 PubMed DOI PMC
Rauschenbach L, Bartsch P, Santos AN et al (2022) Quality of life and mood assessment in conservatively treated cavernous malformation-related epilepsy. Brain Behav 12:e2595. https://doi.org/10.1002/brb3.2595 PubMed DOI PMC
Akers A, Al-Shahi Salman R, Awad AI et al (2017) Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the angioma alliance scientific advisory board clinical experts panel. Neurosurgery 80:665–680. https://doi.org/10.1093/neuros/nyx091 PubMed DOI PMC
Gao X, Yue K, Sun J et al (2020) Treatment of cerebral cavernous malformations presenting with seizures: a systematic review and meta-analysis. Front Neurol 11:590589. https://doi.org/10.3389/fneur.2020.590589 PubMed DOI PMC
Régis J, Bartolomei F, Kida Y et al (2000) Radiosurgery for epilepsy associated with cavernous malformation: retrospective study in 49 patients. Neurosurgery 47:1091–1097 PubMed DOI
Shen C-C, Sun MH, Yang M-Y et al (2021) Outcome of intracerebral cavernoma treated by Gamma Knife radiosurgery based on a double-blind assessment of treatment indication. Radiat Oncol Lond Engl 16:164. https://doi.org/10.1186/s13014-021-01885-4 DOI
Engel J, Wiebe S, French J et al (2003) Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 60:538–547. https://doi.org/10.1212/01.wnl.0000055086.35806.2d PubMed DOI
Zabramski JM, Wascher TM, Spetzler RF et al (1994) The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg 80:422–432. https://doi.org/10.3171/jns.1994.80.3.0422 PubMed DOI
R Core Team. R: A Language and environment for statistical computing. R Foundation for Statistical Computing. HttpswwwR-Proj.
Nagy G, Stokes SS, Erőss LG et al (2018) Contemporary radiosurgery of cerebral cavernous malformations: Part 2. Treatment outcome for hemispheric lesions. J Neurosurg. https://doi.org/10.3171/2018.2.JNS171267 PubMed DOI
Lee C-C, Wang W-H, Yang H-C et al (2019) Gamma Knife radiosurgery for cerebral cavernous malformation. Sci Rep 9:19743. https://doi.org/10.1038/s41598-019-56119-1 PubMed DOI PMC
He K, Jiang S, Song J et al (2017) Long-term outcomes of surgical treatment in 181 patients with supratentorial cerebral cavernous malformation-associated epilepsy. World Neurosurg 108:869–875. https://doi.org/10.1016/j.wneu.2017.08.095 PubMed DOI
Rinkel LA, Al-Shahi Salman R, Rinkel GJ, Greving JP (2019) Radiosurgical, neurosurgical, or no intervention for cerebral cavernous malformations: a decision analysis. Int J Stroke Off J Int Stroke Soc 14:939–945. https://doi.org/10.1177/1747493019851290 DOI
von der Brelie C, Malter MP, Niehusmann P et al (2013) Surgical management and long-term seizure outcome after epilepsy surgery for different types of epilepsy associated with cerebral cavernous malformations. Epilepsia 54:1699–1706. https://doi.org/10.1111/epi.12327 PubMed DOI
Shih Y-C, Chou C-C, Peng S-J et al (2022) Clinical characteristics and long-term outcome of cerebral cavernous malformations-related epilepsy. Epilepsia 63:2056–2067. https://doi.org/10.1111/epi.17309 PubMed DOI
Ruan D, Yu X-B, Shrestha S et al (2015) The role of hemosiderin excision in seizure outcome in cerebral cavernous malformation surgery: a systematic review and meta-analysis. PloS One 10:e0136619. https://doi.org/10.1371/journal.pone.0136619 PubMed DOI PMC
St Ggeorge EJ, Perks J, Plowman PN (2002) Stereotactic radiosurgery XIV: The role of the haemosiderin “ring” in the development of adverse reactions following radiosurgery for intracranial cavernous malformations: a sustainable hypothesis. Br J Neurosurg 16:385–391. https://doi.org/10.1080/026886902100007632 DOI